MurataevaN, DhopeshwarkarA, YinD, et al.Where's my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol. Pharmacol Res. 2016; 110:173–180.
BerenbaumMC. What is synergy?. Pharmacol Rev. 1989; 41:93–141.
5.
TallaridaRJ, PorrecaF, CowanA. Statistical analysis of drug–drug and site–site interactions with isobolograms. Life Sci. 1989; 45:947–961.
6.
DeLongGT, WolfCE, PoklisA, et al.Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol. Drug Alcohol Depend. 2010; 112:126–133.
7.
NielsenS, SabioniP, TrigoJM, et al.Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology. 2017; 42:1752–1765.
8.
BerenbaumMC. A method for testing for synergy with any number of agents. J Infect Dis. 1978; 137:122–130.
9.
BoggsDL, NguyenJD, MorgensonD, et al.Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinol. Neuropsychopharmacology, 2018; 43:142–154.
10.
MoralesP, HurstDP, ReggioPH. Molecular targets of the phytocannabinoids: a complex picture. In: KinghornAD, FalkH, GibbonsS, KobayashiJ, eds. Phytocannabinoids, unraveling the complex chemistry and pharmacology of Cannabis sativa.Springer: Cham, Switzerland, 2017.
11.
MurphyM, MillsS, WinstoneJ, et al.Chronic adolescent Δ9-tetrahydrocannabinol treatment of male mice leads to long-Term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment. Cannabis Cannabinoid Res. 2017; 2:235–246.
12.
MaffeiME, GertschJ, AppendinoG. Plant volatiles: production, function and pharmacology. Nat Prod Rep. 2011; 28:1359–1380.
13.
GertschJ, LeontiM, RadunerS, et al.Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A. 2008; 105:9099–9104.
14.
ChenA. Some of the parts: is marijuana's “entourage effect” scientifically valid? Sci Am., April 20, 2017.
